Muhammad Latif - Publications

2011-2012 Bioorganic Science Division Korea Research Institute of Chemical Technology, Republic of Korea 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nazir Y, Saeed A, Rafiq M, Afzal S, Ali A, Latif M, Zuegg J, Hussein WM, Fercher C, Barnard RT, Cooper MA, Blaskovich MAT, Ashraf Z, Ziora ZM. Hydroxyl substituted benzoic acid/cinnamic acid derivatives: Tyrosinase inhibitory kinetics, anti-melanogenic activity and molecular docking studies. Bioorganic & Medicinal Chemistry Letters. 126722. PMID 31732410 DOI: 10.1016/j.bmcl.2019.126722  0.52
2019 Iqbal Z, Iqbal A, Ashraf Z, Latif M, Hassan M, Nadeem H. Synthesis and docking studies of N-(5-(alkylthio)-1,3,4-oxadiazol-2-yl)methyl)benzamide analogues as potential alkaline phosphatase inhibitors. Drug Development Research. PMID 31032540 DOI: 10.1002/ddr.21542  0.52
2018 Mah S, Jang J, Song D, Shin Y, Latif M, Jung Y, Hong S. Discovery of fluorescent 3-heteroarylcoumarin derivatives as novel inhibitors of anaplastic lymphoma kinase. Organic & Biomolecular Chemistry. PMID 30534706 DOI: 10.1039/c8ob02874e  0.56
2018 Aqeel MT, Ur-Rahman N, Khan AU, Ashraf Z, Latif M, Rafique H, Rasheed U. Antihyperlipidemic studies of newly synthesized phenolic derivatives: in silico and in vivo approaches. Drug Design, Development and Therapy. 12: 2443-2453. PMID 30127594 DOI: 10.2147/DDDT.S158554  0.52
2018 Hashmi JA, Almatrafi A, Latif M, Nasir A, Basit S. An 18 bps in-frame deletion mutation in RUNX2 gene is a population polymorphism rather than a pathogenic variant. European Journal of Medical Genetics. PMID 29960047 DOI: 10.1016/j.ejmg.2018.06.013  0.52
2017 Abbas Q, Ashraf Z, Hassan M, Nadeem H, Latif M, Afzal S, Seo SY. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies. Drug Design, Development and Therapy. 11: 2029-2046. PMID 28740364 DOI: 10.2147/DDDT.S137550  0.52
2017 Basit S, Ashraf Z, Lee K, Latif M. First macrocyclic 3(rd)-generation ALK inhibitor for treatment of ALK/ROS1 cancer: Clinical and designing strategy update of lorlatinib. European Journal of Medicinal Chemistry. 134: 348-356. PMID 28431340 DOI: 10.1016/j.ejmech.2017.04.032  0.52
2016 Al-Barry MA, Albalawi AM, Sayf MA, Badawi A, Afzal S, Latif M, Samman MI, Basit S. Sequence analysis of four vitamin D family genes (VDR, CYP24A1, CYP27B1 and CYP2R1) in Vogt-Koyanagi-Harada (VKH) patients: identification of a potentially pathogenic variant in CYP2R1. Bmc Ophthalmology. 16: 172. PMID 27716192 DOI: 10.1186/s12886-016-0354-6  0.52
2016 Choe H, Pham TT, Lee JY, Latif M, Park H, Kang YK, Lee J. Remote Stereoinductive Intramolecular Nitrile Oxide Cycloaddition: Asymmetric Total Synthesis and Structure Revision of (-)-11beta-Hydroxycurvularin. The Journal of Organic Chemistry. PMID 26894643 DOI: 10.1021/acs.joc.5b02760  0.84
2015 Latif M, Yun JI, Seshadri K, Kim HR, Park CH, Park H, Kim H, Lee J. Stereoselective construction of 2,6-cis-disubstituted tetrahydropyrans via intramolecular amide enolate alkylation: total synthesis of (-)-centrolobine. The Journal of Organic Chemistry. 80: 3315-20. PMID 25723100 DOI: 10.1021/acs.joc.5b00046  0.84
2014 Shaikh Qureshi WM, Latif ML, Parker TL, Pratten MK. Evaluation of bupropion hydrochloride developmental cardiotoxic effects in chick cardiomyocyte micromass culture and stem cell derived cardiomyocyte systems. Birth Defects Research. Part B, Developmental and Reproductive Toxicology. 101: 371-8. PMID 25250843 DOI: 10.1002/bdrb.21121  0.84
2014 Lee HJ, Latif M, Choe H, Ali I, Lee HK, Yang EH, Yun JI, Chae CH, Jung JK, Kim HR, Lee CO, Park CH, Lee K. ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatment. Archives of Pharmacal Research. 37: 1130-8. PMID 24446111 DOI: 10.1007/s12272-013-0323-z  0.84
2014 Yun JI, Yang EH, Latif M, Lee HJ, Lee K, Yun CS, Park CH, Lee CO, Chae CH, Cho SY, Jung HJ, Kim P, Choi SU, Kim HR. Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities. Archives of Pharmacal Research. 37: 873-81. PMID 24129617 DOI: 10.1007/s12272-013-0247-7  0.84
2013 Park CH, Choe H, Jang IY, Kwon SY, Latif M, Lee HK, Lee HJ, Yang EH, Yun JI, Chae CH, Cho SY, Choi SU, Ha JD, Jung H, Kim HR, et al. Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment. Bioorganic & Medicinal Chemistry Letters. 23: 6192-6. PMID 24095090 DOI: 10.1016/j.bmcl.2013.08.090  0.84
2009 Saeed A, Khera RA, Latif M, Parvez M. 4-Chloro-N-cyclo-hexyl-benzamide. Acta Crystallographica. Section E, Structure Reports Online. 65: o1539. PMID 21582827 DOI: 10.1107/S1600536809021217  0.84
Show low-probability matches.